• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » The CenterWatch Weekly, May 09, 2016

The CenterWatch Weekly, May 09, 2016

May 9, 2016
CenterWatch Staff

Surprise Quintiles-IMS Health merger may signal rising value of data assets

In a move that sent shockwaves through the life sciences industry last week, Quintiles Transnational Holdings and IMS Health Holdings announced an all-stock merger of equals—a transaction that ranks as the largest CRO merger in history. The com­bined equity market capitalization of the two companies is more than $17.6 billion, and the enterprise value is more than $23 billion. “The surprising thing is that this is an enormous deal for this space,” said Tim Evans, senior analyst at Wells Fargo Securities Equity Research. “The strategic significance remains to be seen, but the big picture here is that data is going to matter a lot more in terms of how clinical trials are conducted.”

 

McConnell Centers for Innovative Medicine is the new model for patient engagement

 The McConnell Centre for Innovative Medicine (CIM), a standalone research institution just a skywalk away from the Research Institute at McGill University Health Centre (RI-MUHC), has opened. The new RI-MUHC super hospital and research center is designed to connect physicians, nurses and researchers. By work­ing together, they can develop and evaluate complex medical problems and make use of industry innovation, including diagnostic tools and therapies.

 

To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing